Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
High Blood Press Cardiovasc Prev ; 26(3): 175-182, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31054064

ABSTRACT

Structural and functional arterial properties commonly impair with aging process. These effects on vasculature could act at many levels from microcirculation to large vessels. Above normal aging process classic cardio-vascular risk factors (hypertension, diabetes mellitus, dyslipidemia, etc.) accelerate the physiological process leading to premature structural and functional alterations that has also been termed early vascular aging. Target organ damage evaluation could be clinically important since these alterations precede by many years' cardiovascular events and so their assessment can predict the onset of more serious and costly events giving the opportunity to prevent CV events by earlier therapeutic intervention. This review will focus on large artery functional properties and particularly on the role of inflammation on the aortic stiffening process.


Subject(s)
Aging , Arteries/physiopathology , Inflammation/physiopathology , Vascular Diseases/physiopathology , Vascular Remodeling , Vascular Stiffness , Age Factors , Animals , Arteries/metabolism , Arteries/pathology , Humans , Inflammation/diagnosis , Inflammation/metabolism , Inflammation/pathology , Inflammation Mediators/metabolism , Prognosis , Pulse Wave Analysis , Risk Factors , Signal Transduction , Vascular Diseases/diagnosis , Vascular Diseases/metabolism , Vascular Diseases/pathology
2.
Ann Cardiothorac Surg ; 8(1): 116-122, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30854320

ABSTRACT

Extracorporeal membrane oxygenation (ECMO) in the veno-arterial (VA) configuration is an established method for the treatment of refractory cardiogenic shock. Such a condition characterizes the postoperative course of approximatively 1% of cardiac surgery patients. Although some studies have reported ECMO-related short-term results, little is known about the long-term outcomes of VA-ECMO therapy in the post-cardiotomy setting. Therefore, an extensive literature search was conducted regarding articles published after 1990 reporting postoperative ECMO use. PubMed, EMBASE and Web of Science were searched for sources. In-hospital mortality was high in post-cardiotomy VA-ECMO patients, ranging from 24.8% to 52%. Long-term results were poorly reported. However, based on the limited information available, hospital survivors showed a favorable outcome, with improvement in overall clinical condition, quality of life and limited hospital readmission for cardiac-related events. To conclude, in-hospital outcome in post-cardiotomy ECMO is often unfavorable, post-discharge results show satisfactory condition, with stable improvement of overall patient clinical status and low rate of hospital readmission and cardiac-related adverse events. Data reporting is, however, scarce and hence new and detailed studies are still warranted to investigate such aspects.

3.
J Clin Hypertens (Greenwich) ; 20(1): 193-200, 2018 01.
Article in English | MEDLINE | ID: mdl-29171717

ABSTRACT

Heterogeneous results have been obtained in the relationship between serum uric acid (SUA) and target organ damage (TOD) in patients with hypertension. Clinic blood pressure, SUA, and cardiac, arterial (carotid and aortic), and renal TOD were assessed in 762 consecutive patients with hypertension. Hyperuricemia was defined as an SUA >7.0 in men and >6.0 mg/dL in women. Men with hyperuricemia compared with those with normal SUA showed lower estimated glomerular filtration rates and E/A ratios and a higher prevalence of carotid plaques. Women with hyperuricemia showed lower estimated glomerular filtration rates and E/A ratios and a higher intima-media thickness. Except for pulse wave velocity, all TODs significantly correlated with SUA. However, at multivariate analysis, only estimated glomerular filtration rate was significantly determined by SUA. Our data provide evidence on the role of SUA in the development of TOD only in the case of renal alteration. It is likely that SUA may indirectly act on the other TODs through the increase in blood pressure and the decrease in glomerular filtration rate.


Subject(s)
Carotid Artery Diseases , Carotid Intima-Media Thickness , Hypertension , Hyperuricemia , Kidney Diseases , Uric Acid/blood , Adult , Aged , Carotid Artery Diseases/diagnosis , Carotid Artery Diseases/etiology , Correlation of Data , Cross-Sectional Studies , Female , Glomerular Filtration Rate , Humans , Hypertension/blood , Hypertension/complications , Hypertension/diagnosis , Hypertension/physiopathology , Hyperuricemia/diagnosis , Hyperuricemia/epidemiology , Italy/epidemiology , Kidney Diseases/diagnosis , Kidney Diseases/etiology , Male , Middle Aged , Prevalence , Pulse Wave Analysis , Sex Factors , Vascular Stiffness
4.
Thromb Res ; 155: 78-85, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28521259

ABSTRACT

BACKGROUND: Deficiency of the von Willebrand factor-cleaving protease ADAMTS13 is central to the pathophysiology of thrombotic thrombocytopenic purpura (TTP), a microangiopathic syndrome that presents as an acute medical emergency. In this review we will explore the evidence of a two-way relationship between TTP and ACS. Moreover, we will review the evidence emerged from epidemiological studies of an inverse relationship between the plasma levels of ADAMTS13 and the risk of ACS. METHODS AND RESULTS: Pubmed, MEDLINE and EMBASE, CINHAL, COCHRANE and Google Scholar databases were searched from inception to January 2017. The search yielded 43 studies representing 23 unique patient cases, 5 case series, 5 cohort studies and 10 case-control studies. Most ACS cases developing in the setting of TTP resolved with standard treatment of the underlying microangiopathy, with only a few requiring coronary invasive management. Antiplatelet therapy was not usually prescribed and all of the currently used P2Y12 were felt to be a potential trigger for a TTP-like syndrome, although our review revealed that the occurrence of TTP in patients treated with new P2Y12 antagonists is rare. Most studies confirmed the inverse association among ADAMTS13 levels and ACS. CONCLUSIONS: The heart is a definite target organ in TTP. The clinical spectrum of its involvement is probably influenced by local factors that add on to the systemic deficiency characteristic of TTP. It follows that patients with TTP should be carefully monitored for ACS events, especially when multiple risk factors for coronary disease exist.


Subject(s)
ADAMTS13 Protein/metabolism , Acute Coronary Syndrome/etiology , Acute Coronary Syndrome/metabolism , Purpura, Thrombotic Thrombocytopenic/complications , Purpura, Thrombotic Thrombocytopenic/metabolism , von Willebrand Factor/metabolism , ADAMTS13 Protein/blood , Acute Coronary Syndrome/blood , Acute Coronary Syndrome/therapy , Coronary Vessels/metabolism , Humans , Male , Middle Aged , Platelet Aggregation Inhibitors/therapeutic use , Purinergic P2Y Receptor Antagonists/therapeutic use , Purpura, Thrombotic Thrombocytopenic/blood , Purpura, Thrombotic Thrombocytopenic/therapy
5.
PLoS One ; 12(4): e0175766, 2017.
Article in English | MEDLINE | ID: mdl-28419142

ABSTRACT

We describe an 8-spot confocal setup for high-throughput smFRET assays and illustrate its performance with two characteristic experiments. First, measurements on a series of freely diffusing doubly-labeled dsDNA samples allow us to demonstrate that data acquired in multiple spots in parallel can be properly corrected and result in measured sample characteristics consistent with those obtained with a standard single-spot setup. We then take advantage of the higher throughput provided by parallel acquisition to address an outstanding question about the kinetics of the initial steps of bacterial RNA transcription. Our real-time kinetic analysis of promoter escape by bacterial RNA polymerase confirms results obtained by a more indirect route, shedding additional light on the initial steps of transcription. Finally, we discuss the advantages of our multispot setup, while pointing potential limitations of the current single laser excitation design, as well as analysis challenges and their solutions.


Subject(s)
DNA/analysis , Microscopy/instrumentation , Spectrometry, Fluorescence/instrumentation , DNA-Directed RNA Polymerases/metabolism , Diffusion , Equipment Design , Escherichia coli/enzymology , Escherichia coli/genetics , High-Throughput Screening Assays/instrumentation , Kinetics , Lasers , Microscopy, Confocal/instrumentation , Promoter Regions, Genetic , Transcription, Genetic
7.
High Blood Press Cardiovasc Prev ; 22(4): 411-6, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26458940

ABSTRACT

Renal denervation (RD) is an intriguing treatment strategy for resistant hypertension. However, limited data are available about its long time efficacy as well as its effects on intermediate phenotypes like arterial stiffness and carotid IMT. 12 patients (9 males, mean 69 years) with resistant hypertension underwent bilateral RDN (Medtronic System) since April 2012 in Niguarda Ca' Granda Hospital (Milan). Patients were studied before intervention, and at 1, 3, 6 and 12 months after RD. Carotid intima media thickness (Esaote Mylab) and carotid-femoral pulse wave velocity (Complior, Alam medical) were assessed at each step. Compared to baseline, patients showed a marked reduction of office systolic blood pressure at each follow-up step (p < 0.05 versus baseline for all steps) as well as pulse wave velocity (p < 0.01 at 1 year versus baseline). Moreover, reduction in pulse wave velocity was higher than the expected value obtained only considering blood pressure drop. Conversely, no significant effect was observed on diastolic blood pressure as well as carotid intima-media thickness. In our study, renal denervation was a safe and effective procedure. The BP lowering effect was maintained during follow-up and a beneficial effect on arterial stiffness was observed, which implies that this effect can't passively originate from the BP fall but rather from an improvement of arterial mechanical properties, possibly related to a reduced sympathetic arterial drive.


Subject(s)
Blood Pressure , Drug Resistance , Hypertension/surgery , Kidney/innervation , Sympathectomy/methods , Vascular Stiffness , Aged , Aged, 80 and over , Antihypertensive Agents/therapeutic use , Blood Pressure/drug effects , Carotid Intima-Media Thickness , Female , Humans , Hypertension/diagnosis , Hypertension/physiopathology , Italy , Male , Middle Aged , Prospective Studies , Pulse Wave Analysis , Time Factors , Treatment Outcome
8.
Proc SPIE Int Soc Opt Eng ; 85902013 Feb 02.
Article in English | MEDLINE | ID: mdl-24371508

ABSTRACT

Single-molecule fluorescence spectroscopy of freely diffusing molecules in solution is a powerful tool used to investigate the properties of individual molecules. Single-Photon Avalanche Diodes (SPADs) are the detectors of choice for these applications. Recently a new type of SPAD detector was introduced, dubbed red-enhanced SPAD (RE-SPAD), with good sensitivity throughout the visible spectrum and with excellent timing performance. We report a characterization of this new detector for single-molecule fluorescence resonant energy transfer (smFRET) studies on freely diffusing molecules in a confocal geometry and alternating laser excitation (ALEX) scheme. We use a series of doubly-labeled DNA molecules with donor-to-acceptor distances covering the whole range of useful FRET values. Both intensity-based (µs-ALEX) and lifetime-based (ns-ALEX) measurements are presented and compared to identical measurements performed with standard thick SPADs. Our results demonstrate the great potential of this new detector for smFRET measurements and beyond.

9.
Proc SPIE Int Soc Opt Eng ; 85902013 Feb 22.
Article in English | MEDLINE | ID: mdl-24386541

ABSTRACT

Single-molecule Förster resonance energy transfer (smFRET) techniques are now widely used to address outstanding problems in biology and biophysics. In order to study freely diffusing molecules, current approaches consist in exciting a low concentration (<100 pM) sample with a single confocal spot using one or more lasers and detecting the induced single-molecule fluorescence in one or more spectrally- and/or polarization-distinct channels using single-pixel Single-Photon Avalanche Diodes (SPADs). A large enough number of single-molecule bursts must be accumulated in order to compute FRET efficiencies with sufficient statistics. As a result, the minimum timescale of observable phenomena is set by the minimum acquisition time needed for accurate measurements, typically a few minutes or more, limiting this approach mostly to equilibrium studies. Increasing smFRET analysis throughput would allow studying dynamics with shorter timescales. We recently demonstrated a new multi-spot excitation approach, employing a novel multi-pixel SPAD array, using a simplified dual-view setup in which a single 8-pixel SPAD array was used to collect FRET data from 4 independent spots. In this work we extend our results to 8 spots and use two 8-SPAD arrays to collect donor and acceptor photons and demonstrate the capabilities of this system by studying a series of doubly labeled dsDNA samples with different donor-acceptor distances ranging from low to high FRET efficiencies. Our results show that it is possible to enhance the throughput of smFRET measurements in solution by almost one order of magnitude, opening the way for studies of single-molecule dynamics with fast timescale once larger SPAD arrays become available.

SELECTION OF CITATIONS
SEARCH DETAIL
...